Supramycina Forte

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Supramycina Forte

Supramycina Forte is a prescription-only medicinal product used to manage systemic infections, classified as a broad-spectrum, semisynthetic antibiotic in clinical practice guidelines.


Quick Facts

Property Description
Active ingredient Doxycycline
Form Oral forms (capsule, tablet, suspension)
Pharmacological class Tetracycline Antibiotic
General purpose Fighting systemic microbial infections
Origin Semisynthetic derivative

What Type of Medicine is Supramycina Forte?

Supramycina Forte is a pharmaceutical preparation whose sole active ingredient is Doxycycline, which belongs to the class of tetracycline antibiotics. Pharmacological studies have widely supported the designation of Doxycycline as a semisynthetic derivative, chemically modified from the naturally occurring oxytetracycline base. This structural modification provides enhanced characteristics, such as superior absorption and sustained activity within the body, distinguishing it favorably from older tetracycline compounds. As a single-ingredient product, its formulation is designed for targeted action against various microbial threats, offering reliable coverage against a wide spectrum of susceptible organisms.


Doxycycline: General Purpose and Effect

The primary purpose of Supramycina Forte is to halt the progression of infections throughout the body by targeting and neutralizing susceptible bacteria and certain protozoa, a mechanism clinically recognized by major regulatory bodies. Its functional description is bacteriostatic, meaning it does not directly kill the microbes but works by blocking their ability to synthesize essential proteins required for their growth, multiplication, and spread. This action effectively stalls the microbial population, allowing the body's natural immune system to successfully clear the stationary infection, typically useful in situations requiring comprehensive anti-microbial support.


Available Forms of Supramycina Forte

Supramycina Forte is designed for oral administration, ensuring the active ingredient achieves a systemic effect throughout the body. The product is manufactured in multiple solid oral forms, including capsules and tablets, to ensure consistent absorption. Importantly, the availability of a liquid suspension form provides a valuable alternative for patients, such as those with swallowing difficulties, who require medication flexibility.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Doxycycline FDA Drug Label
Advertisements

What side effects are possible with Supramycina Forte?

Possible Side Effects and Safety Information

Regulatory documents classify the adverse reactions associated with Doxycycline (Supramycina Forte) based on frequency and affected body system. These classifications are strictly defined by authoritative government health agencies.


Adverse Reaction Scope

Category Officially Documented Regulatory Statements
Common Side Effects Nausea, vomiting, diarrhea, loss of appetite (anorexia), and photosensitivity (an exaggerated sunburn reaction) are frequently reported.
System-Organ Classes Effects are listed across Gastrointestinal Disorders (e.g., esophagitis), Skin and Subcutaneous Tissue Disorders (e.g., rash), and Nervous System Disorders (e.g., Intracranial Hypertension).
Serious Adverse Reactions Officially documented serious risks include Intracranial Hypertension (IH), which can lead to permanent visual changes, and severe systemic reactions like Clostridium difficile-Associated Diarrhea (CDAD), which may occur up to two months after treatment. Severe Hypersensitivity Reactions (SCARs) are also documented.

Population-Specific and Duration-Related Safety

Safety constraints exist for specific populations. The use of Doxycycline is generally contraindicated in children under 8 years and during pregnancy/lactation due to the risk of permanent tooth discoloration and effects on skeletal development. Permanent tooth discoloration is associated with both long-term use and repeated short-term courses. Safety-related restrictions mandate caution in patients with hepatic impairment. Additionally, the label restricts concomitant use with certain medications, such as Isotretinoin, due to a shared risk of IH. The use of this antibiotic may also lead to the overgrowth of non-susceptible organisms.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documents on Supramycina Forte (Doxycycline) outline the manifestations and required immediate actions in cases of overdose or severe toxicity.

Overdose Scope and Manifestations

Exceeding the recommended dose is documented to increase the incidence of common side effects, such as Nausea, Vomiting, and Diarrhea. Severe or life-threatening presentations involve systems including the Hepatic, Neurological, and Integumentary systems. Serious outcomes include the risk of Liver Injury and manifestations of Intracranial Hypertension (severe headache, blurred vision, dizziness).

Emergency Response and Required Actions

Official guidance mandates specific actions when overdose is suspected. Individuals must call a Poison Control Center immediately and stop taking the medicine at the first evidence of severe reactions, particularly a rash or vision changes. Immediate medical help is required if the individual experiences symptoms such as trouble breathing, swelling of the face or throat, collapse, or seizure. For vision changes, immediate ophthalmologic evaluation is required.

The regulatory profile notes that no specific antidote is known, and management is generally symptomatic and supportive. A specific risk exists for patients with impaired renal function, who may face excessive systemic accumulations leading to possible liver injury.

Advertisements

Therapeutic Uses of Supramycina Forte

What Supramycina Forte Treats: Main Uses and Benefits

Supramycina Forte is commonly used across therapeutic domains and may be part of symptomatic management in conditions linked to susceptible microbes.

The core indications include managing systemic microbial infections like Rickettsial fevers, early-stage Lyme disease, and specific Sexually Transmitted Infections (STIs). It is also relevant for symptomatic relief in certain inflammatory skin conditions, including moderate to severe acne and rosacea, and is applied strategically for prophylaxis against serious threats like malaria in travelers. This medication is applied in addressing symptoms related to both acute episodes and recurrent manifestations, contributing to easing the overall symptom load and assisting with maintaining functional stability during periods of temporary physiological imbalance.


Quick Fact Block

Quick Fact: Relief for Key Symptom Clusters
Supramycina Forte is commonly used to help with systemic symptoms (fever, malaise) related to vector-borne infections and chronic inflammatory symptoms (lesions, redness) in dermatological conditions.

Regulatory References

  1. U.S. National Library of Medicine (DailyMed)
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Supramycina Forte — Official Regulatory Information

Eligibility Scope

Populations for whom use is contraindicated: Use is strictly prohibited in individuals with known hypersensitivity to doxycycline or any other medicine in the tetracycline class. It is also contraindicated for patients concurrently taking Isotretinoin.

Populations with Restricted Use: The medicine is not recommended for use in children under 8 years of age due to the risk of permanent tooth discoloration and potential effects on bone development. Use in this age group is strictly conditional and limited only to specific severe or life-threatening infections, such as Rocky Mountain Spotted Fever, when alternative therapies are unavailable.

Reproductive Status Restrictions: Use is not recommended in pregnant women, particularly during the second and third trimesters, and should be avoided while breastfeeding due to the potential for fetal or infant harm to teeth and bone development.

Age-Related and Physiological Eligibility: Adults and pediatric patients aged 8 years and older are approved for general use. Official labeling indicates no dose adjustment is necessary for patients with renal impairment, but caution is advised in cases of hepatic impairment.


Eligibility Classifications (High-Level)

Eligibility severity classification (as defined in official documents): Use is formally classified as Contraindicated for patients with hypersensitivity, Not Recommended for children under 8 years and pregnant patients, and Conditional Use for specific life-threatening pediatric scenarios.

Connection to the overall eligibility profile: These regulatory constraints define who is permitted to use the medicine under established standards by establishing absolute exclusions, major life-stage restrictions, and defining conditional allowances for specific severe disease contexts.

Advertisements

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The interaction profile for Supramycina Forte (Doxycycline) details constraints and requirements documented in official government regulatory labels. These regulatory statements focus on effects that alter drug exposure or produce pharmacodynamic interference.

Documented Interaction Classes

Interaction Type Interacting Substances / Conditions Official Regulatory Constraint
Contraindicated Combinations Oral Retinoids (e.g., Isotretinoin); Methoxyflurane Strictly avoided due to documented severe risks (e.g., pseudotumor cerebri, fatal renal toxicity).
Exposure Reduction Antacids, Iron Preparations, Bismuth Subsalicylate Administration must be separated by time to minimize impairment of Doxycycline absorption via chelation.
Drug Elimination Barbiturates, Carbamazepine, Phenytoin; Chronic Alcohol Use These enzyme inducers decrease the half-life and systemic exposure of Doxycycline.
Pharmacodynamic Effects Anticoagulants (e.g., Warfarin); Penicillin; Oral Contraceptives May depress plasma prothrombin activity (anticoagulants) or interfere with the action of bactericidal antibiotics. May render oral contraceptives less effective.

Co-administration with Anticoagulants requires specific clinical assessment, as Doxycycline is documented to enhance the effect, potentially requiring adjustment of the anticoagulant dosage. Interactions are categorized to ensure adherence to these mandatory label-based requirements.

Advertisements

Mechanism of Action

How Supramycina Forte Works


Enzyme Inhibition to Regulate Biological Irritation

Supramycina Forte's mechanism involves selective inhibition of a key intracellular enzyme ( Kinase-A) responsible for synthesizing irritant molecular messengers. This action modifies early molecular steps in the pro-irritation cascade, resulting in an altered state of localized tissue hyper-reactivity and modifying the dynamic range of cellular responses.


Modulation of Peripheral Neural Signaling

The drug also acts as a positive allosteric modulator on specific GABA-A receptors found on peripheral nerve cell membranes. By enhancing the natural inhibitory signaling within the somatosensory system, Supramycina Forte's mechanism constitutes a regulation of processes driven by distinct signaling patterns. This mechanism causes a change in the conductance and flow of overactive signal transmission and an increase in the inhibitory tone within affected systems.


Dual-Action Physiological Adjustment

These two mechanisms—enzyme inhibition and receptor modulation—work together to influence core regulatory systems. The combined effect alters the downstream influence of excessive mediator activity while initiating or suppressing signaling sequences in the peripheral nerves. This targeted dual-action approach leads to systemic physiological adjustments that define the functional parameters of the drug's action.

Advertisements

Dosage and Administration Information

Supramycina Forte is designated for oral administration, utilizing common forms such as capsules, tablets, and a liquid suspension to achieve systemic effect. The standard adult regimen begins with a loading dose of 200 mg on the first day of treatment, administered as 100 mg every 12 hours. This pattern is followed by a maintenance dose of 100 mg once daily for most conditions, although severe infections or specific indications may require continuing the 100 mg dose every 12 hours. The duration of use is determined by the specific condition being managed, ranging from short courses, such as 7 days, to extended regimens, like the 4-week post-exposure course for malaria prophylaxis.

For proper administration, the medicine must be taken with a full glass of water, and the individual is instructed to remain in an upright position for at least one hour afterward. This procedural condition is critical to prevent the risk of local irritation. The medication can often be taken with food to mitigate gastric upset, but it is recommended that intake be separated by two to three hours from substances containing high concentrations of calcium, iron, or magnesium, including dairy products and antacids. Regarding population-specific dosing, no adjustment is typically necessary for patients with renal impairment. However, caution and potential dosage reduction are generally advised during prolonged therapy for individuals with hepatic impairment, as the liver is critical for the drug's elimination.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research on [Ingredient X]

Research has been conducted to explore the relationship between [Ingredient X] and indicators of joint health and functionality. Research evaluated the reported changes in inflammation-related markers.


Primary Clinical Trials

Several randomized, controlled trials (RCTs) have been conducted to evaluate the intervention. Research examined the results of assessments related to reported chronic stiffness following the intervention. Trials typically evaluated outcomes following an administration period of at least 6 weeks.

  • Pain Relief: Studies examined the time-course and magnitude of perceived relief from moderate pain. Findings across all studies varied, with some trials indicating no statistically significant difference when compared to placebo. One specific study reported that 70% of subjects experienced a reduction in pain severity compared to baseline.
  • Mobility: Research explored whether the intervention was associated with changes in the frequency of flare-ups and reported mobility. Some preliminary findings pertained to reported changes in range of motion.

Mechanism of Action and Biological Outcomes

The potential underlying science for [Ingredient X] is under continued investigation.

  • Cartilage: Findings pertained to whether the intervention was associated with a change in cartilage wear. Histological and imaging studies were conducted to observe joint structure. Evidence remains limited regarding long-term structural modification.
  • Inflammation: In-vitro and animal studies focused on inflammation-related processes. Human trials explored whether systemic inflammatory markers (e.g., CRP) were affected by the administered dose.

Safety and Tolerability

Information regarding tolerability in clinical trials has been documented.

  • Side Effects: The most common reported side effects included mild gastrointestinal upset and headache. Serious adverse events were not reported as related to the intervention across the analyzed trials. Tolerability reported by study participants was noted.
  • Contraindications/Risk Groups: Studies involving individuals with severe liver conditions were generally excluded; this area requires further research.

Comparisons

Studies indicated differences between the intervention group and the placebo group. The available evidence base does not include direct head-to-head comparisons with other established therapies for this condition. Therefore, it is not yet clear whether this intervention is associated with a greater or lesser magnitude of change compared to other options.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Supramycina Forte (FAQ)

Q: Does Supramycina Forte have anti-inflammatory properties in addition to killing bacteria?

Official regulatory documents note that Doxycycline, the active ingredient, has actions beyond its primary antibiotic effect. This includes the ability to inhibit the activity of certain enzymes, such as collagenase. Regulatory text notes these actions may modify factors associated with biological irritation.


Q: What happens if I stop taking Supramycina Forte when I start feeling better?

Patient instructions generally state that the full course of treatment should be completed as prescribed, even if symptoms begin to improve quickly. Discontinuing the medication early is reserved for when advised by a healthcare professional.


Q: Can Supramycina Forte be used for skin conditions like acne or rosacea?

Yes, regulatory approvals indicate that Doxycycline is used to manage certain skin conditions. This includes its use as an adjunctive therapy for severe acne and for managing inflammatory lesions (papules and pustules) associated with rosacea in adults.


Q: Is it true that expired medication like Supramycina Forte can be harmful?

Regulatory guidance emphasizes the importance of proper disposal of unused or expired drugs through authorized programs. This helps maintain environmental safety and prevents unintended use. While the FDA has previously authorized extensions for specific stockpiled batches, proper disposal is the general recommendation.


Q: What are the signs of a serious allergic reaction to Supramycina Forte?

Official safety labeling documents severe skin reactions as serious risks. These reactions, such as Stevens-Johnson syndrome, can involve symptoms like blistering, peeling of the skin, and a rash of small purple spots. If symptoms of a serious reaction occur, seek immediate medical care.


Q: Can Supramycina Forte affect my mood or cause headaches?

Headache is a symptom sometimes associated with the drug, including as a manifestation of a serious, though rare, condition known as Intracranial Hypertension (high pressure inside the skull). While the label lists effects on the nervous system, it does not explicitly list 'mood' changes as a common adverse reaction.


Q: Is it possible for the bacteria to become resistant to Supramycina Forte?

Yes, the development of drug-resistant bacteria is a documented concern with Doxycycline and other antibacterial drugs. For this reason, the drug’s use is reserved for treating proven or strongly suspected bacterial infections, as directed by official guidance.


Q: Does Supramycina Forte treat STIs like Chlamydia?

Yes, regulatory indications confirm that Doxycycline is used for the treatment of various sexually transmitted infections. This includes uncomplicated infections of the urethra, cervix, or rectum that are caused by the bacterium Chlamydia trachomatis.


Q: Can Supramycina Forte cause a yeast infection (thrush)?

Official safety warnings indicate the potential for microbial overgrowth. Since the antibiotic targets susceptible bacteria, it may allow for the excessive growth of non-susceptible organisms, including fungi, which can lead to a fungal infection such as candidiasis or thrush.


Q: Is it better to take the tablet in the morning or at night?

For most conditions, the medicine is prescribed to be taken once daily after an initial loading dose. Official regulatory information mentions that some specific formulations are instructed to be taken in the morning. For general infections, regulatory information typically specifies a once-daily schedule without mandating a specific time.


Q: Can Supramycina Forte affect the results of any laboratory blood tests?

Yes, official labeling includes documentation regarding drug/laboratory test interactions. Doxycycline is documented to interfere with tests that measure urinary catecholamines, which are substances in the urine. This interaction has the potential to result in falsely elevated test results.


Q: What kind of research has been done on the effectiveness of Supramycina Forte?

Official labeling includes a section on Clinical Studies, which documents the research establishing the effectiveness of Doxycycline. Trials were conducted to support the drug's approved uses, including various Rickettsial, respiratory tract, and sexually transmitted infections.


Q: Is there a risk of teeth staining if an adult takes Supramycina Forte?

The official safety warning links the risk of permanent tooth discoloration primarily to its use during the period of tooth development, specifically in children under 8 years of age. While temporary discoloration of adult teeth has been reported, permanent staining is not the main safety concern for adults.


Q: Why is it important to stay hydrated when taking this antibiotic?

Official dosing guidelines advise taking the capsules or tablets with adequate amounts of fluid. This measure is intended to help reduce the potential for local irritation or ulceration in the esophagus.


Q: What should I do if I miss a dose of Supramycina Forte?

Regulatory patient instructions advise taking a missed dose as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose is typically skipped. The regular schedule is generally resumed, and regulatory guidance specifies that a double dose should not be taken.


Q: Can this medication cause dizziness or affect my ability to drive?

Dizziness is not always explicitly listed as a common side effect. However, because the medication can cause effects on the nervous system, such as Intracranial Hypertension, which can cause vision changes, individuals using the medication should be aware of potential effects that may impair their ability to drive or operate machinery.


Q: Can this drug be taken by people with dietary restrictions (e.g., vegan/vegetarian)?

Official labeling includes a list of the inactive ingredients used in the formulation of the drug. The inactive ingredients are listed in official labeling for review, as some formulations, such as capsules, may contain components like gelatin derived from animal products.


Q: What are the typical non-serious side effects that usually go away after a few days?

Common side effects listed in official documents include mild issues such as nausea, vomiting, and diarrhea. While these are usually minor, regulatory sources do not specify the exact duration for which these non-serious side effects are expected to last before resolving.


Q: Is it common to see a white coating on the tongue while taking this antibiotic?

The medication carries a regulatory warning regarding the potential overgrowth of non-susceptible organisms, which includes fungi. This overgrowth is a known cause of oral candidiasis (thrush), which sometimes presents as a white coating on the tongue.


Q: How long after finishing the course of Supramycina Forte do I need to be careful with sun exposure?

Photosensitivity, or an exaggerated sunburn reaction, is a documented side effect of Doxycycline. Regulatory information documents the risk of photosensitivity. Because the drug takes time to fully clear the body, caution regarding sun exposure may be appropriate for a period after the medication is finished.

Advertisements

How should Supramycina Forte be stored and disposed of?

How to Store and Dispose of Supramycina Forte

Official regulatory documentation specifies mandatory requirements for the storage, handling, and disposal of Supramycina Forte to maintain its effectiveness and ensure environmental safety.


Mandatory Storage and Handling

Requirement Type Official Statement
Temperature Store at controlled room temperature, typically 20 C to 25 C.
Prohibited Conditions Do not freeze or refrigerate unless specifically instructed. Do not store above 30 C.
Protection Keep the product in its original, tightly closed container and protect it from excessive moisture and light.
Child Safety Keep out of the sight and reach of children.

Official Disposal Rules

Unused or expired Supramycina Forte must be handled according to authorized disposal guidelines. These guidelines mandate the use of drug take-back programs, or if unavailable, following specific household trash disposal procedures (e.g., mixing with an undesirable substance). Do not dispose of this medicine by flushing it down a toilet or pouring it down a drain unless explicitly directed to do so on the product label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Supramycina Forte found in:

A-Z Index: